Download App

Log in to access Online Inquiry
Company Overview More
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton’s Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
CEO: Hasnain, Faheem
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > GOSS Gossamer Bio > Detailed Quotes

GOSS Gossamer Bio

7.480-0.160-2.09%
Close 05/20 20:00 ET
7.48000.00%
Post Mkt Price 05/20 16:00 ET
High
7.745
Open
7.690
Turnover
5.73M
Low
6.880
Pre Close
7.640
Volume
789.34K
Market Cap
576.83M
P/E(TTM)
Loss
52wk High
14.300
Shares
77.12M
P/E(Static)
Loss
52wk Low
6.275
Float Cap
459.33M
Bid/Ask %
0.00%
Historical High
27.150
Shs Float
61.41M
Volume Ratio
0.95
Historical Low
6.275
Dividend TTM
--
Div Yield TTM
1000
P/B
19.13
Dividend LFY
--
Div Yield LFY
13368.98%
Turnover Ratio
1.29%
Amplitude
11.32%
Avg Price
7.263
Lot Size
1
Float Cap
459.33M
Bid/Ask %
0.00%
Historical High
27.150
Shs Float
61.41M
Volume Ratio
0.95
Historical Low
6.275
Dividend TTM
--
P/B
19.13
Dividend LFY
--
Turnover Ratio
1.29%
Amplitude
11.32%
Avg Price
7.263
Lot Size
1
Price Forecast

No Data

News

Comment